John William Allen Jr, MD - Medicare Internal Medicine in Olive Branch, MS

John William Allen Jr, MD is a medicare enrolled "Internal Medicine" physician in Olive Branch, Mississippi. He went to University Of Mississippi School Of Medicine and graduated in 1998 and has 26 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice Primary Care Group, Llc, Methodist Inpatient Physicians Llc, Methodist Inpatient Physicians Llc and his current practice location is 5480 Goodman Rd Ste 1, Olive Branch, Mississippi. You can reach out to his office (for appointments etc.) via phone at (662) 874-6507.

John William Allen Jr is licensed to practice in Mississippi (license number 17289) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1801868666.

Contact Information

John William Allen Jr, MD
5480 Goodman Rd Ste 1,
Olive Branch, MS 38654-7902
(662) 874-6507
(662) 932-8197



Physician's Profile

Full NameJohn William Allen Jr
GenderMale
SpecialityInternal Medicine
Experience26 Years
Location5480 Goodman Rd Ste 1, Olive Branch, Mississippi
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • John William Allen Jr attended and graduated from University Of Mississippi School Of Medicine in 1998
  NPI Data:
  • NPI Number: 1801868666
  • Provider Enumeration Date: 02/06/2006
  • Last Update Date: 02/02/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 8224010186
  • Enrollment ID: I20040603001151

Medical Identifiers

Medical identifiers for John William Allen Jr such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1801868666NPI-NPPES
Q007099MedicaidTN
199932001MedicaidAR
00124398MedicaidMS

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208M00000XHospitalist 17289 (Mississippi)Secondary
208M00000XHospitalist 50030 (Tennessee)Secondary
207R00000XInternal Medicine 50030 (Tennessee)Secondary
207R00000XInternal Medicine 17289 (Mississippi)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Sta Home Health And HospiceGreenwood, MSHome health agency
Baptist Home Care And Hospice North MississippiBatesville, MSHome health agency
Homechoice Health Services, IncHernando, MSHome health agency
Methodist Healthcare - Olive Branch HospitalOlive branch, MSHospital
Baptist Memorial Hospital DesotoSouthaven, MSHospital
Methodist Healthcare Memphis HospitalsMemphis, TNHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Primary Care Group, Llc0941480131108
Methodist Inpatient Physicians Llc1254241235112
Methodist Inpatient Physicians Llc1254241235112

News Archive

European women soon to have access to new breast cancer drug

European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.

Researchers discover crucial link between metabolism and osteoarthritis

Osteoarthritis can potentially be prevented with a good diet and regular exercise, a new expert review published in the Nature Reviews Rheumatology reports.

SBP researcher awarded $10.8 million grant to pursue development of new drug for substance abuse

Sanford Burnham Prebys Medical Discovery Institute is pleased to announce the National Institute on Drug Abuse at the National Institutes of Health has awarded Nicholas Cosford, Ph.D., a three-year, $10.8 million grant to pursue the preclinical development of a new class of medicine to treat substance use disorders.

Counting number of endothelial cells in blood may predict cancer treatment's effectiveness

Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.

Prevalence of vaccine breakthrough cases in SF Bay Area

A new study focuse on studying breakthrough infections in a highly vaccinated community owing to the emergence of SARS-CoV-2 variants.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. John William Allen Jr allows following entities to bill medicare on his behalf.
Entity NameNorth Mississippi Medical Center Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1972608347
PECOS PAC ID: 9931010600
Enrollment ID: O20040413000541

News Archive

European women soon to have access to new breast cancer drug

European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.

Researchers discover crucial link between metabolism and osteoarthritis

Osteoarthritis can potentially be prevented with a good diet and regular exercise, a new expert review published in the Nature Reviews Rheumatology reports.

SBP researcher awarded $10.8 million grant to pursue development of new drug for substance abuse

Sanford Burnham Prebys Medical Discovery Institute is pleased to announce the National Institute on Drug Abuse at the National Institutes of Health has awarded Nicholas Cosford, Ph.D., a three-year, $10.8 million grant to pursue the preclinical development of a new class of medicine to treat substance use disorders.

Counting number of endothelial cells in blood may predict cancer treatment's effectiveness

Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.

Prevalence of vaccine breakthrough cases in SF Bay Area

A new study focuse on studying breakthrough infections in a highly vaccinated community owing to the emergence of SARS-CoV-2 variants.

Read more Medical News

› Verified 1 days ago

Entity NamePrimary Care Group, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093016651
PECOS PAC ID: 0941480131
Enrollment ID: O20110920000312

News Archive

European women soon to have access to new breast cancer drug

European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.

Researchers discover crucial link between metabolism and osteoarthritis

Osteoarthritis can potentially be prevented with a good diet and regular exercise, a new expert review published in the Nature Reviews Rheumatology reports.

SBP researcher awarded $10.8 million grant to pursue development of new drug for substance abuse

Sanford Burnham Prebys Medical Discovery Institute is pleased to announce the National Institute on Drug Abuse at the National Institutes of Health has awarded Nicholas Cosford, Ph.D., a three-year, $10.8 million grant to pursue the preclinical development of a new class of medicine to treat substance use disorders.

Counting number of endothelial cells in blood may predict cancer treatment's effectiveness

Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.

Prevalence of vaccine breakthrough cases in SF Bay Area

A new study focuse on studying breakthrough infections in a highly vaccinated community owing to the emergence of SARS-CoV-2 variants.

Read more Medical News

› Verified 1 days ago

Entity NameCarr, Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1548677610
PECOS PAC ID: 1850512153
Enrollment ID: O20160707000686

News Archive

European women soon to have access to new breast cancer drug

European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.

Researchers discover crucial link between metabolism and osteoarthritis

Osteoarthritis can potentially be prevented with a good diet and regular exercise, a new expert review published in the Nature Reviews Rheumatology reports.

SBP researcher awarded $10.8 million grant to pursue development of new drug for substance abuse

Sanford Burnham Prebys Medical Discovery Institute is pleased to announce the National Institute on Drug Abuse at the National Institutes of Health has awarded Nicholas Cosford, Ph.D., a three-year, $10.8 million grant to pursue the preclinical development of a new class of medicine to treat substance use disorders.

Counting number of endothelial cells in blood may predict cancer treatment's effectiveness

Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.

Prevalence of vaccine breakthrough cases in SF Bay Area

A new study focuse on studying breakthrough infections in a highly vaccinated community owing to the emergence of SARS-CoV-2 variants.

Read more Medical News

› Verified 1 days ago

Entity NameMethodist Inpatient Physicians Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1609850692
PECOS PAC ID: 1254241235
Enrollment ID: O20170202002322

News Archive

European women soon to have access to new breast cancer drug

European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.

Researchers discover crucial link between metabolism and osteoarthritis

Osteoarthritis can potentially be prevented with a good diet and regular exercise, a new expert review published in the Nature Reviews Rheumatology reports.

SBP researcher awarded $10.8 million grant to pursue development of new drug for substance abuse

Sanford Burnham Prebys Medical Discovery Institute is pleased to announce the National Institute on Drug Abuse at the National Institutes of Health has awarded Nicholas Cosford, Ph.D., a three-year, $10.8 million grant to pursue the preclinical development of a new class of medicine to treat substance use disorders.

Counting number of endothelial cells in blood may predict cancer treatment's effectiveness

Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.

Prevalence of vaccine breakthrough cases in SF Bay Area

A new study focuse on studying breakthrough infections in a highly vaccinated community owing to the emergence of SARS-CoV-2 variants.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. John William Allen Jr is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
John William Allen Jr, MD
1211 Union Ave Ste 330,
Memphis, TN 38104-6655

Ph: () -
John William Allen Jr, MD
5480 Goodman Rd Ste 1,
Olive Branch, MS 38654-7902

Ph: (662) 874-6507

News Archive

European women soon to have access to new breast cancer drug

European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.

Researchers discover crucial link between metabolism and osteoarthritis

Osteoarthritis can potentially be prevented with a good diet and regular exercise, a new expert review published in the Nature Reviews Rheumatology reports.

SBP researcher awarded $10.8 million grant to pursue development of new drug for substance abuse

Sanford Burnham Prebys Medical Discovery Institute is pleased to announce the National Institute on Drug Abuse at the National Institutes of Health has awarded Nicholas Cosford, Ph.D., a three-year, $10.8 million grant to pursue the preclinical development of a new class of medicine to treat substance use disorders.

Counting number of endothelial cells in blood may predict cancer treatment's effectiveness

Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.

Prevalence of vaccine breakthrough cases in SF Bay Area

A new study focuse on studying breakthrough infections in a highly vaccinated community owing to the emergence of SARS-CoV-2 variants.

Read more News

› Verified 1 days ago


Internal Medicine Doctors in Olive Branch, MS

Javed Abdullah, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 4250 Bethel Rd, 5th Floor, Olive Branch, MS 38654
Phone: 901-763-0200    Fax: 901-761-4002
Douglas Thaggard, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 4250 Bethel Rd, Olive Branch, MS 38654
Phone: 901-516-1290    Fax: 901-516-1220
Dr. Shailesh Mansukh Patel, D.O.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 4250 Bethel Rd, Olive Branch, MS 38654
Phone: 901-516-1290    Fax: 901-516-1220
Jawwad Yusuf, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 4250 Bethel Rd Fl 5, Olive Branch, MS 38654
Phone: 901-763-0200    Fax: 901-761-4002
Dakshin Gangadharamurthy, MD
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 4250 Bethel Rd, Olive Branch, MS 38654
Phone: 901-516-1290    Fax: 901-516-1220
Wendy Michelle Ballenger, DO
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 7148 Kerr Street Place, Suite 110, Olive Branch, MS 38654
Phone: 662-222-6724    Fax: 901-350-5024
James Riddell Lewis, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 4250 Bethel Rd, Olive Branch, MS 38654
Phone: 901-516-1290    Fax: 901-516-1220

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.